A study in patients with MS demonstrated that elevated plasma MMP-9 levels were independently associated with MS and correlated with increased cardiovascular risk, suggesting a link between high MMP-9 levels and poor CV outcomes [28]. Here, MMP9 is linked to myeloid sarcoma.